P ro d u c t D e s ig n A g re e m e n t

Th is P rod u c t D e sig n Ag re e m e n t (th e “Ag re e m e n t” or “P rod u c t D e sig n A g re e m e n t”) sta te s th e

te rm s a n d c on d ition s th a t g ove rn th e c on tra c tu a l a g re e m e n t b e tw e e n A D E W A L E A Y O M IP O S I,
a n d C O V E N W O R K S h avin g its p rin c ip a l p la c e of b u sin e ss a t 29 0 9 E A rk a n s a s L n , A rlin g to n
Te x a s 76 0 11 (th e “C lie n t”) w h o a g re e s to b e b ou n d by th is Ag re e m e n t.

W H E R E A S th e C lie n t h a s in itia te d th e d eve lop m e n t p roc e ss of a C om m u n ity B a se d M ob ile

A p p lic a tion (th e “P roje c t F O F O ”), w h ic h is d e sc rib e d in fu rth e r d e ta il on P rod u c t R e q u ire m e n t
D oc u m e n t, a n d th e P rod u c t D e sig n e r is a c on tra c tor w ith w h om th e C lie n t h a s c om e to a n
a g re e m e n t to d e sig n th e M ob ile A p p lic a tion U I.

N O W , TH E R E F O R E , In c on sid e ra tion of th e m u tu a l c ove n a n ts a n d p rom ise s m a d e by th e p a rtie s

to th is P rod u c t D e sig n Ag re e m e n t, th e P rod u c t D e sig n e r a nd th e C lie n t (in d ivid u a lly, ea c h a
“P a rty” a n d c olle c tive ly, th e “P a rtie s”) c ove n a n t a n d a g re e a s follow s:

1. P rod u c t D e sig n e r ’s d u tie s

Th e C lie n t h e re by e n g a g e s th e P rod u c t D e sig n e r a n d th e P rod u c t D e sig n e r h e re by a g re e s to b e

e n g a g e d by th e C lie n t to d e sig n th e M ob ile A p p lic a tion U I in a c c ord a n c e w ith th e sp e c ifi c a tion s
a tta c h e d h e re to a s P rod u c t R e q u ire m e n t D oc u m e n t (th e “S p e c ifi c a tion s”).

1. Th e P rod u c t D e sig n e r sh a ll c om p le te th e d e sig n of th e M ob ile A p p lic a tion U I a c c ord in g to

th e m ile ston e s d e sc rib e d on th e form a tta c h e d h e re to a s E xh ib it B . In a c c ord a n c e w ith
su c h m ile ston e s, th e fi n a l p rod u c t sh a ll b e d e live re d to th e C lie n t by 12th J a n u a ry 20 22 (th e
“D e live ry D a te”).

2. F or a p e riod of 8 w e e k s a fte r d e live ry of th e fi n a l p rod u c t, th e P rod u c t D e sig n e r sh a ll

p rovid e th e C lie n t a tte n tion to a n sw e r an y q u e stion s or a ssist in solvin g a n y p rob le m s w ith
re g a rd to th e im p le m e n ta tion of th e M ob ile A p p lic a tion U I.

Th e P rod u c t D e sig n e r a g re e s to re sp on d to a n y rea son a b le re q u e st for a ssista n c e m a d e by

th e C lie n t re g a rd in g th e M ob ile A p p lic a tion U I w ith in 30 H ou rs of th e re q u e st.

3. E xc e p t a s exp re ssly p rovid e d in th is P rod u c t D e sig n Ag re e m e n t, th e C lie n t sh a ll n ot b e

ob lig a te d u n d e r th is Ag re e m e n t to p rovid e a n y oth e r su p p ort or a ssista n c e to th e P rod u c t
D e sig n e r.
 4 . Th e C lie n t m ay te rm in a te th is P rod u c t D e sig n Ag re e m e n t a t a n y tim e u p on m a te ria l
b rea c h of th e te rm s h e re in a n d fa ilu re to c u re su c h a b rea c h w ith in 4 w e e k s of n otifi c a tion
of su c h a b rea c h .

2. D e live ry

Th e M ob ile A p p lic a tion U I sh a ll fu n c tion in a c c ord a n c e w ith th e S p e c ifi c a tion s on or b e fore th e

D e live ry D a te .

1. If th e M ob ile A p p lic a tion U I a s d e live re d d oe s n ot c on form w ith th e S p e c ifi c a tion s, th e

C lien t sh a ll w ith in 2 W e e k s of th e D e live ry D a te n otify th e P rod u c t D e sig n e r in w ritin g of th e w ays
in w h ic h it d oe s n ot c on form w ith th e S p e c ifi c a tion s. Th e P rod u c t D e sig n e r a g re e s th a t u p on
re c e ivin g su c h n otic e , it sh a ll m a k e rea son a b le e fforts to c orre c t a n y n on -c on form ity.

2. Th e C lie n t sh a ll p rovid e to th e P rod u c t D e sig n e r w ritte n n otic e of its fi n d in g th a t th e

M ob ile A p p lic a tion U I c on form s to th e S p ec ifi c a tion s w ith in 2 w e e k s of th e D e live ry D a te (th e
“Ac c e p ta n c e D a te”) u n le ss it fi n d s th a t th e M ob ile A p p lic a tion U I d oe s n ot c on form to th e
S p e c ifi c a tion s a s d e sc rib e d in S e c tion 2(A ) h e re in .

3. In te lle c tu a l p rop e rty rig h ts in th e M ob ile A p p lic a tion U I

Th e P a rtie s a c k n ow le d g e a n d a g re e th a t th e C lie n t w ill h old a ll in te lle c tu a l p rop e rty rig h ts in th e

M ob ile A p p lic a tion U I in c lu d in g , b u t n ot lim ite d to, c opyrig h t a n d tra d e m a rk rig h ts. Th e P rod u c t
D e sig n e r a g re e s n ot to c la im a n y su c h ow n e rsh ip in th e M ob ile A p p lic a tion U I’s in te lle c tu a l
p rop e rty a t a n y tim e p rior to or a fte r th e c om p le tion a n d d e live ry of th e M ob ile A p p lic a tion U I to
th e C lie n t.

4 . C h a n g e in sp e c ifi c a tion s

Th e C lie n t m ay re q u e st th a t rea son a b le c h a n g e s b e m a d e to th e S p e c ifi c a tion s a n d ta sk s

a ssoc ia te d w ith th e im p le m e n ta tion of th e S p ec ifi c a tion s. If th e C lie n t re q u e sts su c h a c h a n g e ,
th e P rod u c t D e sig n e r w ill u se its b e st e fforts to im p le m e n t th e re q u e ste d c h a n g e a t n o a d d ition a l
exp e n se to th e C lie n t a n d w ith ou t d e layin g d e live ry of th e M ob ile A p p lic a tion U I. In th e eve n t th a t
th e p rop ose d c h a n g e w ill, in th e sole d isc re tion of th e P rod u c t D e sig n e r, re q u ire a d e lay in th e
d e live ry of th e M ob ile A p p lic a tion U I or w ou ld re su lt in a dd ition a l exp e n se to th e C lie n t, th e n th e
C lie n t a n d th e P rod u c t D e sig n e r sh a ll c on fe r a n d th e C lie n t m ay e ith e r w ith d raw th e p rop ose d
c h a n g e or re q u ire th e P rod u c t D e sig n e r to d e live r th e M ob ile A p p lic a tion U I w ith th e p rop ose d
c h a n g e a n d su b je c t to th e d e lay a n d /or a d d ition a l exp e n se . Th e C lie n t a g re e s a n d a c k n ow le d g e s
th a t th e ju d g m e n t a s to if th e re w ill b e a n y d e lay or a d d ition a l exp e n se sh a ll b e m a d e sole ly by
th e P rod u c t D e sig n e r.

5. C on fi d e n tia lity

Th e P rod u c t D e sig n e r sh a ll n ot d isc lose to a n y th ird p a rty th e b u sin e ss of th e C lie n t, d e ta ils

re g a rd in g th e M ob ile A p p lic a tion U I, in c lu d in g , w ith ou t lim ita tion a n y in form a tion re g a rd in g th e
M ob ile A p p lic a tion U I’s e le m e n ts, th e S p e c ifi c a tion s, or th e C lie n t’s b u sin e ss (th e “C on fi d e n tia l
In form a tion ”), (ii) m a k e c op ie s of a n y C on fi d e n tia l In form a tion or a n y c on te n t b a se d on th e
c on c e p ts c on ta in e d w ith in th e C on fi d e n tia l In form a tion for p e rson a l u se or for d istrib u tion u n le ss
re q u e ste d to d o so by th e C lie n t, or (iii) u se C on fi d e n tia l In form a tion oth e r th a n sole ly for th e
b e n e fi t of th e C lie n t .

6 . P rod u c t D e sig n e r w a rra n tie s

Th e P rod u c t D e sig n e r re p re se n ts a n d w a rra n ts to th e C lie n t th e follow in g :

1. d e sig n a n d d e live ry of th e M ob ile A p p lic a tion U I u n d e r th is A g re e m e n t a re n ot in viola tion

of an y oth e r a g re e m e n t th a t th e P rod u c t D e sig n e r h a s w ith a n oth e r p a rty.

2. Th e M ob ile A p p lic a tion U I w ill n ot viola te th e in te lle c tu a l p rop e rty rig h ts of a n y oth e r p a rty.

3. F or a p e riod of 12 w e e k s a fte r th e D e live ry D a te , th e M ob ile A p p lic a tion U I sh a ll op e ra te

a c c ord in g to th e S p e c ifi c a tion s. If th e M ob ile A p p lic a tion U I m a lfu n c tion s or in a n y w ay
d oe s n ot op e ra te a c c ord in g to th e S p e c ifi c a tion s w ith in tha t tim e , th e n th e P rod u c t
D e sig n e r sh a ll ta k e a n y rea son a b ly n e c e ssa ry ste p s to fi x th e issu e a n d e n su re th e M ob ile
A p p lic a tion U I op e ra te s a c c ord in g to th e S p e c ifi c a tion s.

7. In d e m n ifi c a tion

Th e P rod u c t D e sig n e r a g re e s to in d e m n ify, d e fe n d , a n d p rote c t th e C lie n t f rom a n d a g a in st a ll

law su its a n d c osts of eve ry k in d p e rta in in g to th e M ob ile A p p lic a tion U I in c lu d in g rea son a b le le g a l
fe e s d u e to th e P rod u c t D e sig n e r ’s in f rin g e m e n t of th e in te lle c tu a l rig h ts of a n y th ird p a rty.
 8 . N o m od ifi c a tion u n le ss in w ritin g

N o m od ifi c a tion of th is Ag re e m e n t sh a ll b e va lid u n le ss in w ritin g a n d a g re e d u p on by b oth

P a rtie s.

9. A p p lic a b le law

Th is P rod u c t D e sig n Ag re e m e n t a n d th e in te rp re ta tion of its te rm s sh a ll b e g ove rn e d by a n d

c on stru e d in a c c ord a n c e w ith th e law s of th e S ta te of [Texa s] a n d su b je c t to th e exc lu sive
ju risd ic tion of th e fe d e ra l a n d sta te c ou rts loc a te d in [U n ite d S ta te s of A m e ric a ], [D a lla s, Texa s]

IN W ITN E S S W H E R E O F , ea c h of th e P a rtie s h a s exe c u te d th is P rod u c t D e sig n Ag re e m e n t, b oth

P a rtie s by its d u ly a u th orize d offi c e r, a s of th e d ay a n d yea r se t forth b e low .

P R O D U C T D E S IG N E R ’S N A M E : AYOMIPOSI PHILEMON ADEWALE

D ATE S IG N E D : 24/12/2021

C L IE N TS ’ AU TH O R IZE D O F F IC E R :
C L IE N TS ’ S IG N ATU R E :

D ATE S IG N E D :